Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that the company will present data from ...

Biotech Vertex, known for its cystic fibrosis therapies, is set to report earnings on Feb. 12 ...

NAD⁺ is a coenzyme central to redox reactions, shuttling electrons in metabolic pathways and thereby supporting ATP ...

Researchers report that intermittent CO2 breathing can stimulate the brain’s glymphatic system. In a proof-of-concept study, ...

Prosecutors say the executives were encouraging investors to buy more stocks for the drug knowing that it had been denied ...

The FDA is expected to decide on treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I.

There is a history of studying relaxin in cardiovascular settings—Novartis started a phase 3 heart failure trial of a recombinant relaxin-2 peptide in 2013—but preclinical evidence of the molecule’s ...

Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.

Nektar Therapeutics (NASDAQ:NKTR) stock rose 3% Tuesday morning after the company reported positive maintenance data from its REZOLVE-AD study for rezpegaldesleukin in patients with moderate-to-severe ...

Shares of Nektar Therapeutics (NASDAQ:NKTR) moved higher on Tuesday after the company released encouraging long-term ...

Don't be too quick to get rid of that dusty old CRT TV, as there are loads of clever ways to repurpose and breathe new life into these retro sets.

The current industry focus is on 1.6T transceivers, but the roadmap to 3.2T requires a shift to 200G and 400G per-lane intensity modulation (IM-DD). Polariton’s plasmonic ring resonator modulators ...